The World Health Organization warned that artificial sweeteners, used to replace sugar in a vast range of products, do not help in losing weight and can have serious health effects.
According to the United Nations health agency, a systematic review of available evidence "suggests that use of non-sugar sweeteners (NSS) does not confer any long-term benefit in reducing body fat in adults or children.
In addition, results from the review suggest that the long-term use of NSS could increase the risk of type 2 diabetes, cardiovascular diseases, and mortality in adults.
The WHO's director for nutrition and food safety, Francesco Branca, stressed that replacing ordinary sugar with artificial sweeteners "does not help with weight control in the long term".
He added that NSS are not essential dietary factors and have no nutritional value.
The WHO said its new recommendation applied to everyone except individuals with pre-existing diabetes.
It includes all synthetic and naturally occurring or modified sweeteners not classified as sugars found in manufactured foods and beverages or sold on their own to be added to products by consumers.
Among the most widely used sweeteners are acesulfame K, aspartame, advantame, cyclamates, neotame, saccharin, sucralose, stevia, and stevia derivatives, it said.


Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
FDA Fast-Tracks Approval of Altria’s on! PLUS Nicotine Pouches Under New Pilot Program
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
U.S. Stock Futures Slide as Tech Rout Deepens on Amazon Capex Shock
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Trump Signs Executive Order Threatening 25% Tariffs on Countries Trading With Iran
Australia’s December Trade Surplus Expands but Falls Short of Expectations
South Korea’s Weak Won Struggles as Retail Investors Pour Money Into U.S. Stocks
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies 



